Clicky

Guard Therapeutics International AB(GUARD)

Description: Guard Therapeutics International AB (publ), a pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden. It offers ROSGard, a biological drug candidate that prevents kidney damage by protecting, cleaning, and repairing the exposed cells and tissues. The company was formerly known as A1M Pharma AB (publ) and changed its name to Guard Therapeutics International AB (publ) in October 2019. Guard Therapeutics International AB (publ) was incorporated in 2008 and is based in Stockholm, Sweden.


Keywords: Pharmaceutical Acute Kidney Injuries

Home Page: guardtherapeutics.com

Nybrogatan 34, 2 tr
Stockholm, 114 39
Sweden
Phone: 46 86 70 65 51


Officers

Name Title
Mr. Tobias Larsson Agervald Chief Exec. Officer
Ms. Karin Botha Chief Financial Officer
Mr. Magnus Gram C.S.O
Mr. Peter Gilmour Ph.D. Head of Preclinical Science
Ms. Sara Thuresson Head of Clinical Operations
Dr. Michael Reusch Chief Medical Officer
Mr. Torbjorn Larsson Head of Chemistry, Manufacturing & Controls

Exchange: ST

Country: SE : Sweden

Currency: Swedish krone (kr)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 2.9717
Price-to-Sales TTM: 0
IPO Date:
Fiscal Year End: December
Full Time Employees: 10
Back to stocks